Ask five sources what an SBIR Phase 1 grant amount is and you will get five different numbers: $275,000, $305,000, $314,363, even $323,090. They are not typos, and most of them are not wrong. They describe different things. The reason founders see contradictory figures is that “the Phase I amount” is not one number at all — it is a statutory guideline, an inflation-adjusted guideline, an agency ceiling, and a waiver exception, stacked on top of each other.

The controlling baseline is smaller than almost any blog will tell you. Under the federal SBA SBIR/STTR Policy Directive, a Phase I award — including modifications — “may not exceed $150,000,” and agencies may exceed that guideline “by no more than 50%” without a waiver. Everything above roughly $225,000 that you see quoted comes from either an annual inflation adjustment or an agency-specific ceiling. This article maps each circulating figure back to its source so you know which one applies to your company.

Quick answer:

  • The statutory Phase I guideline is $150,000; agencies can go up to 50% over (~$225,000) without asking SBA. SBA adjusts the guideline for inflation every year, which is why the real ceiling now sits far higher.
  • There is no single Phase I amount. NSF pays a flat $305,000; NIH’s standard Phase I budget is around $306,872 and higher on waiver topics; DoD components run $50,000–$250,000.
  • The agency and the specific solicitation — not a guideline table — control your actual award. Always read the topic’s “Limited Amount of Award” language.
  • The April 2026 reauthorization (through 2031) left standard Phase I ceilings unchanged but added a new Phase II “Strategic Breakthrough” category worth up to $30 million.

Why the SBIR Phase 1 grant amount is four numbers wearing one label

The confusion is structural, not careless. The SBA Policy Directive sets a national guideline, not a fixed price. Three rules then move the real figure away from the headline $150,000. First, an agency “may issue an award that exceeds these award guideline amounts by no more than 50%” on its own authority — that alone takes Phase I to $225,000. Second, SBA “reviews these amounts every year for the effects of inflation” and posts adjusted guidelines on SBIR.gov; the adjusted base is what produces the $314,000-and-up figures circulating in 2026. Third, an agency can request a waiver from SBA to exceed the guideline by more than 50% for a specific topic, and SBA decides within ten business days.

So when one site says $150,000 and another says $323,090, both can be citing the same directive — one is quoting the raw statutory guideline and the other is quoting the inflation-adjusted, waiver-eligible ceiling. The number that matters for your budget is neither of those abstractions. It is the dollar figure printed in the topic you are actually applying to.

What each agency actually pays for SBIR Phase I

Because agencies set their own ceilings under the SBA guideline, the spread across the eleven participating agencies is enormous — the top agency ceiling is more than six times the smallest. Here is where the major funders landed for current Phase I solicitations:

  • NIH (HHS): The standard Phase I budget normally may not exceed roughly $306,872 per its budget-update notice, with higher amounts allowed on a published list of waiver topics. Each NIH institute can set its own limit, so two NIH topics can carry very different caps.
  • NSF: A flat $305,000 for Phase I, inclusive of all direct costs, indirect costs, and the firm fee — raised from $275,000. NSF Phase I now runs 6 to 18 months.
  • DoD (Army, Navy, Air Force/AFWERX, DARPA, Space Force): Roughly $50,000 to $250,000, set per component and per topic. AFWERX open-topic awards are often near $75,000; Army and Navy topics frequently reach $250,000.
  • DOE: Commonly up to $250,000, 6 to 12 months.
  • NASA: Around $150,000 for about 6 months.
  • USDA: Roughly $175,000 for an 8-month period of performance.

The takeaway is not “apply where the ceiling is highest.” A $305,000 NSF award you can win beats a $323,000 NIH topic that has no institute home for your science. If you want to see which agencies are currently soliciting work in your technology area, you can filter live opportunities through OpenGrants’ grant database rather than guessing from a cap table.

Why NSF and NIH numbers look “cleaner” than DoD

NSF and NIH publish a single Phase I budget figure because they run their programs as grants with a standard ceiling. DoD does not have one number because it is not one program — each military branch and defense agency runs its own SBIR shop with its own topics, contract vehicles, and dollar limits. That is why a credible source can say “DoD Phase I is $75,000” and another can say “$250,000” in the same breath. Both describe real DoD topics. For a defense-focused founder, the relevant number is whatever the specific 26.1-series topic on DSIP states, not a program-wide average.

The reauthorization changed the runway, not the Phase I sticker price

SBIR and STTR lapsed on September 30, 2025 and ran without authorization for roughly six months, freezing new solicitations. That ended on April 13, 2026, when the President signed S. 3971, the Small Business Innovation and Economic Security Act, extending both programs through September 30, 2031. SBA’s announcement noted the programs have invested more than $81 billion into over 34,000 small businesses since 1982, naming alumni such as Qualcomm, Illumina, and iRobot.

For Phase I budgeting, the important fact is what the law did not do: it left the standard Phase I and Phase II ceilings alone. The headline new money sits at the other end of the pipeline — a Phase II “Strategic Breakthrough” allocation that lets large agencies (those with SBIR obligations above $100 million) award up to $30 million to a single firm over as much as 48 months, with awards completed within 90 days of proposal receipt. If you are sizing a Phase I budget today, ignore the $30 million number; it does not touch feasibility-stage work.

Two reauthorization rules that will shape your Phase I strategy

Beginning in fiscal year 2027, agencies must set per-firm limits on how many proposals a company can submit per solicitation or per topic — the long-debated response to so-called “SBIR mills” that flooded the system with applications. Agencies must publish those limits at least 90 days before FY2027 begins, and they can waive a limit on an urgent topic for no more than 5% of their topics in a year. Practically, that means the days of spraying dozens of near-identical Phase I proposals across agencies are ending, and a focused, well-matched application matters more than ever.

The second shift is about Phase III. The reauthorization pushes agencies to build commercialization and Phase III contracting capacity. Phase III still has no funding ceiling and is the sole-source vehicle where SBIR companies have landed contracts worth hundreds of millions — so the modest Phase I check is best understood as the entry ticket to that pipeline, not the prize. Founders weighing whether to pursue federal R&D at all can compare it against other small business grant options before committing to a multi-phase path.

How to turn the right number into a fundable budget

Once you have identified the controlling ceiling for your specific topic, build the budget to the work, not to the cap. The SBA directive is explicit that the program is designed “to make a large number of relatively small awards,” and reviewers notice when a budget is padded to hit the maximum without justification. A few rules keep Phase I budgets clean:

  • Read the “Limited Amount of Award” section first. At NIH especially, the institute-level cap can sit well below the program ceiling. The solicitation overrides every table you found online.
  • Account for the firm fee inside the ceiling. NSF’s $305,000, for example, is inclusive of indirect costs and the small-business fee — it is not $305,000 of direct research plus extras.
  • Use the built-in commercialization money. Many agencies fund Technical and Business Assistance (TABA) on top of or within the award — NSF allows up to $6,500 — which is free help most first-time applicants leave on the table.
  • Map the gap to Phase II. Phase I runs out before Phase II starts; plan bridge funding (state grants, DoD Phase I options, NSF Phase IB matching) so feasibility momentum does not stall.

For a deeper pipeline view of how Phase I feeds Phase II and III deadlines across agencies, see OpenGrants’ federal grants hub and the broader library of startup funding guides.

Frequently Asked Questions

What is the maximum SBIR Phase 1 grant amount in current solicitations?

There is no universal maximum. The SBA statutory guideline is $150,000, which agencies may exceed by up to 50% on their own and further by waiver. After inflation adjustments and agency ceilings, the practical top end sits around $305,000 (NSF) to roughly $306,872 and up (NIH waiver topics). DoD components often cap lower, between $50,000 and $250,000. Your actual maximum is whatever your specific topic’s solicitation states.

Why do different websites list different SBIR Phase I amounts?

Because they are quoting different layers of the same rule. Some cite the raw $150,000 statutory guideline, some cite the inflation-adjusted SBA guideline, some cite an individual agency ceiling, and some cite a waiver-topic maximum. All can be technically accurate while disagreeing. Always trace a quoted number back to a primary source — the SBA Policy Directive or the agency solicitation — before you budget against it.

Did the 2026 reauthorization raise the Phase I award amount?

No. The Small Business Innovation and Economic Security Act, signed April 13, 2026, extended SBIR and STTR through 2031 but left standard Phase I and Phase II ceilings unchanged. Its new dollar figure — a Phase II Strategic Breakthrough award of up to $30 million — applies only to large agencies for late-stage, milestone-based work, not to Phase I feasibility awards.

Is the SBIR Phase I award taxable, and does it count as equity?

SBIR funding is non-dilutive: the government takes no equity and no IP ownership, which is a core reason founders pursue it over venture capital. The award is generally treated as business income for tax purposes, so consult a CPA on how it interacts with your R&D expenses and any applicable credits. The non-dilutive nature is the real value — you keep your cap table intact while proving feasibility.

How long does the Phase I money have to last?

Period of performance is typically 6 months at DoD and NASA, up to 12 months at NIH and DOE, and 6 to 18 months at NSF. The award must cover that full window, so divide the ceiling by the months of work to see your real monthly run rate — a $250,000 award over 12 months is a very different budget than the same amount over 6.

Bottom line: chase the right number, not the biggest one

The single most useful move when sizing a SBIR Phase 1 grant amount is to stop searching for one figure and start reading one document: the solicitation for the topic you intend to answer. The $150,000 guideline, the +50% band, the inflation adjustment, and the agency ceiling are all real, but only the topic’s stated cap binds your budget. Pick the agency whose mission your technology fits — NIH for biomedical product development, NSF for broad-market deep tech, DoD when a named defense customer needs your result — and size the budget to the feasibility work rather than to the ceiling.

If you want that mapping done for you — matching your technology to the agencies and open Phase I topics where you can actually win, with the controlling award amounts pulled from each solicitation — start with OpenGrants’ SBIR and STTR funding hub, and bring in OpenGrants’ grant writing team when you are ready to turn the right number into a fundable proposal.